These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy? Beitinjaneh A; Kaufman A; Wang Y; Jain P; Srour SA; Wang M Curr Treat Options Oncol; 2022 Nov; 23(11):1614-1625. PubMed ID: 36227407 [TBL] [Abstract][Full Text] [Related]
4. A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma. Dreyling M; Tam CS; Wang M; Smith SD; Ladetto M; Huang H; Novotny W; Co M; Romano A; Holmgren E; Huang J; Gouill SL Future Oncol; 2021 Jan; 17(3):255-262. PubMed ID: 32985902 [TBL] [Abstract][Full Text] [Related]
5. Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease. Tarockoff M; Gonzalez T; Ivanov S; Sandoval-Sus J Curr Oncol Rep; 2022 Oct; 24(10):1313-1326. PubMed ID: 35639332 [TBL] [Abstract][Full Text] [Related]